Phase-Locked Accelerated Intermittent Theta Burst Stimulation for Treatment-Resistant Depression
Key facts
- Who runs it
- Cheng-Hsin General Hospital
- Where
- Taiwan1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 54 people enrolled
- Started
- 22 May 2024
- Ended
- 15 Apr 2026
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Phase-Locked Accelerated Intermittent Theta Burst Stimulation
- Random-Phase Accelerated Intermittent Theta Burst Stimulation
- Record updated
- 10 November 2026
Who can take part
- Age
- 18 years to 70 years
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 15 criteriaShow less
Who can take part
- Adults aged 18 to 70 years
- Diagnosis of major depressive disorder (MDD)
- Inadequate response to at least two antidepressant trials of adequate dose and duration
- A 17-item Hamilton Depression Rating Scale (HAM-D) score of 9 or higher
- A Montgomery-Åsberg Depression Rating Scale (MADRS) score of 16 or higher
- Willingness to participate in the study and provision of written informed consent
Who cannot take part
- Electroconvulsive therapy (ECT) within the previous 12 months
- Other psychiatric disorders or serious medical conditions
- Psychotic disorders
- Current illicit drug use or alcohol use disorder
- Neurological or seizure disorders
- Contraindications to transcranial magnetic stimulation (TMS), including cardiac pacemakers or metallic implants
- Unstable medical illness
- Pregnancy or postpartum depression
- Inability to comply with study procedures
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study aims to investigate whether synchronizing accelerated intermittent theta burst stimulation (aiTBS) with an individual's ongoing brain activity improves treatment outcomes in adults with Treatment-Resistant Depression (TRD).
Read full original descriptionShow less
Participants were randomly assigned to one of two treatment groups:
1. Phase-locked aiTBS (PL-aiTBS): Magnetic stimulation was synchronized with a specific phase of ongoing brain activity measured using electroencephalography (EEG). 2. Random-phase aiTBS (RP-aiTBS): Participants received the same stimulation protocol without synchronization to a specific phase of brain activity.
Both groups received personalized stimulation based on their individual theta frequency. Treatment consisted of 10 sessions over three consecutive days, with three sessions on Day 1, three sessions on Day 2, and four sessions on Day 3 (3-3-4 schedule). Each session delivered 1,800 magnetic pulses, resulting in a total of 18,000 pulses per participant.
The primary objective was to compare changes in depressive symptoms between the two treatment groups. Depression severity was assessed using the 17-item Hamilton Depression Rating Scale (HAM-D) and the Montgomery-Åsberg Depression Rating Scale (MADRS) at baseline (before the first stimulation session), mid-treatment (after the sixth session, Day 2), post-treatment (after the tenth session, Day 3), and follow-up (Day7).
Resting-state EEG recordings were collected before and after stimulation sessions to investigate treatment-related changes in neural oscillatory activity, phase-amplitude coupling, functional connectivity, and other neurophysiological measures, as well as their potential associations with improvements in depressive symptoms.
The 2 groups in the trial
- Phase-Locked Accelerated iTBS (PL-aiTBS)Treatment being tested
Participants received individualized accelerated intermittent theta burst stimulation (aiTBS) synchronized to a specific phase of ongoing frontal theta oscillations measured using EEG.
Treatment: Phase-Locked Accelerated Intermittent Theta Burst Stimulation
- Random-Phase Accelerated iTBS (RP-aiTBS)Existing treatment, for comparison
Participants received the same individualized aiTBS protocol without phase-locked synchronization to ongoing frontal theta oscillations.
Treatment: Random-Phase Accelerated Intermittent Theta Burst Stimulation
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Development of Precision Medicine in the Field of iTBS on Patients With TRD Using Multimodal Functional Brain Imaging and Deep Learning
- Record updated
- 10 November 2026